Skip to main content
. 2017 Sep 14;8(9):e117. doi: 10.1038/ctg.2017.44

Figure 1.

Figure 1

Flowchart of the study. ATI, antibodies to infliximab; FC, fecal calprotectin; IFX, Infliximab; ITL, Infliximab trough level; PBMC, peripheral blood mononuclear cells; sTNF-α, serum TNF-α tmTNF-α, transmembrane TNF-α.